Shopping Cart
Remove All
Your shopping cart is currently empty
Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that specifically targets influenza A virus by binding the highly conserved stem region of the viral haemagglutinin protein, Gedivumab prevents haemagglutinin maturation and blocking membrane fusion during viral entry within the intranucleosomal environment, and it is extensively applied in influenza A virus infection studies and antiviral therapeutic research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $645 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,460 | - | In Stock | |
| 50 mg | $1,970 | - | In Stock |
| Description | Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that specifically targets influenza A virus by binding the highly conserved stem region of the viral haemagglutinin protein, Gedivumab prevents haemagglutinin maturation and blocking membrane fusion during viral entry within the intranucleosomal environment, and it is extensively applied in influenza A virus infection studies and antiviral therapeutic research. |
| Synonyms | RG7745, RG 7745, MHAA4549A, MHAA 4549A |
| Reactivity | Virus |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | IAV |
| Cas No. | 1807954-17-1 |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.